CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 49 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398,590 | -31.5% | 273,007 | +7.4% | 0.00% | 0.0% |
| Q2 2023 | $582,242 | +213.6% | 254,254 | +24.6% | 0.00% | 0.0% |
| Q1 2023 | $185,683 | -22.3% | 204,047 | -27.4% | 0.00% | 0.0% |
| Q4 2022 | $239,009 | -32.1% | 281,187 | -34.6% | 0.00% | 0.0% |
| Q3 2022 | $352,000 | -1.4% | 429,708 | +19.0% | 0.00% | 0.0% |
| Q2 2022 | $357,000 | -56.8% | 361,034 | -28.4% | 0.00% | -50.0% |
| Q1 2022 | $827,000 | -63.1% | 504,155 | -45.8% | 0.00% | -60.0% |
| Q4 2021 | $2,242,000 | +229.7% | 930,447 | +562.5% | 0.01% | +150.0% |
| Q3 2021 | $680,000 | -17.8% | 140,455 | -54.6% | 0.00% | 0.0% |
| Q2 2021 | $827,000 | -23.0% | 309,653 | -11.2% | 0.00% | -33.3% |
| Q1 2021 | $1,074,000 | +678.3% | 348,756 | +586.9% | 0.00% | +200.0% |
| Q2 2020 | $138,000 | -34.0% | 50,776 | -48.8% | 0.00% | -50.0% |
| Q1 2020 | $209,000 | -64.6% | 99,258 | -8.6% | 0.00% | 0.0% |
| Q4 2019 | $591,000 | +206.2% | 108,599 | +69.6% | 0.00% | +100.0% |
| Q3 2019 | $193,000 | +10.3% | 64,048 | +36.6% | 0.00% | 0.0% |
| Q2 2019 | $175,000 | -31.9% | 46,904 | -26.6% | 0.00% | 0.0% |
| Q1 2019 | $257,000 | +2.0% | 63,861 | -7.0% | 0.00% | 0.0% |
| Q4 2018 | $252,000 | – | 68,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,749,379 | $18,147,000 | 3.77% |
| VR Adviser, LLC | 3,427,461 | $16,589,000 | 2.13% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $15,854,000 | 2.04% |
| Telemetry Investments, L.L.C. | 196,168 | $949,000 | 1.28% |
| DC Investments Management, LLC | 50,709 | $245,000 | 0.46% |
| Orbimed Advisors | 6,943,654 | $33,607,000 | 0.37% |
| EcoR1 Capital, LLC | 2,081,077 | $10,072,000 | 0.35% |
| BVF INC/IL | 1,370,947 | $6,635,000 | 0.26% |
| Ikarian Capital, LLC | 757,545 | $3,666,000 | 0.26% |
| CHI Advisors LLC | 165,927 | $803,000 | 0.23% |